The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rapifen 500 micrograms/ml solution for injection or infusion

Piramal Critical Care B.V.PA22583/001/001

Main Information

Trade NameRapifen 500 micrograms/ml solution for injection or infusion
Dosage FormSolution for injection/infusion
Licence HolderPiramal Critical Care B.V.
Licence NumberPA22583/001/001

Group Information

ATC CodeN01AH Opioid anesthetics
N01AH02 alfentanil


License statusAuthorised
Licence Issued09/06/1992
Legal statusNot applicable
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back